Solid Biosciences Inc.
Symbol: SLDB
NASDAQ
10.23
USDTržní cena dnes
-2.2174
Poměr P/E
0.0499
Poměr PEG
386.25M
MRK Cap
- 0.00%
Výnos DIV
Solid Biosciences Inc. (SLDB) finanční výkazy
Rozvaha
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 612.23 | 123.6 | 213.7 | 207.8 | |||||||||
balance-sheet.row.short-term-investments | 232.96 | 49.6 | 58.3 | 88.6 | |||||||||
balance-sheet.row.net-receivables | 0 | 0 | 0 | 0.1 | |||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 6 | |||||||||
balance-sheet.row.other-current-assets | 14.25 | 6.1 | 5.9 | 8.7 | |||||||||
balance-sheet.row.total-current-assets | 636.16 | 129.7 | 219.6 | 222.6 | |||||||||
balance-sheet.row.property-plant-equipment-net | 139.54 | 33.2 | 38.6 | 7.6 | |||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.long-term-investments | 7.33 | 1.8 | 1.8 | 2.1 | |||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.other-non-current-assets | 0.94 | 0.2 | 0.2 | 0.1 | |||||||||
balance-sheet.row.total-non-current-assets | 147.82 | 35.2 | 40.6 | 9.8 | |||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-assets | 783.98 | 164.9 | 260.3 | 232.4 | |||||||||
balance-sheet.row.account-payables | 12.49 | 2 | 3.2 | 4.5 | |||||||||
balance-sheet.row.short-term-debt | 9.14 | 2.3 | 2.6 | 1.5 | |||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.long-term-debt-total | 99.13 | 23.9 | 26 | 0.6 | |||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||
balance-sheet.row.other-current-liab | 22.88 | 10.2 | 16.7 | 9.6 | |||||||||
balance-sheet.row.total-non-current-liabilities | 99.13 | 23.9 | 26.1 | 0.6 | |||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.capital-lease-obligations | 105.95 | 23.9 | 28.5 | 2.1 | |||||||||
balance-sheet.row.total-liab | 165.62 | 38.5 | 48.6 | 24.2 | |||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.common-stock | 0.08 | 0 | 0 | 0.1 | |||||||||
balance-sheet.row.retained-earnings | -2507.41 | -658.8 | -562.7 | -476.8 | |||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0.04 | 0 | -0.1 | 0 | |||||||||
balance-sheet.row.other-total-stockholders-equity | 3125.66 | 785.2 | 774.5 | 684.9 | |||||||||
balance-sheet.row.total-stockholders-equity | 618.36 | 126.5 | 211.7 | 208.2 | |||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 783.98 | 164.9 | 260.3 | 232.4 | |||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-equity | 618.36 | 126.5 | 211.7 | 208.2 | |||||||||
balance-sheet.row.total-liabilities-and-total-equity | 783.98 | - | - | - | |||||||||
Total Investments | 234.79 | 51.5 | 58.3 | 88.6 | |||||||||
balance-sheet.row.total-debt | 108.27 | 26.3 | 28.5 | 2.1 | |||||||||
balance-sheet.row.net-debt | -271 | -47.8 | -126.8 | -117.1 |
Výkaz peněžních toků
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -96.02 | -96 | -86 | -72.2 | |||||||||
cash-flows.row.depreciation-and-amortization | 2.96 | 2.6 | 2.4 | 3 | |||||||||
cash-flows.row.deferred-income-tax | -46.06 | -13.6 | 0 | 1.2 | |||||||||
cash-flows.row.stock-based-compensation | 7.63 | 7.6 | 7.5 | 13.4 | |||||||||
cash-flows.row.change-in-working-capital | -6.34 | -6.3 | -3.7 | -23 | |||||||||
cash-flows.row.account-receivables | 0 | 0 | 0.1 | -0.1 | |||||||||
cash-flows.row.inventory | 0 | 0 | 0 | -11.5 | |||||||||
cash-flows.row.account-payables | -0.76 | -0.8 | -5.2 | 1.2 | |||||||||
cash-flows.row.other-working-capital | -4.67 | -5.6 | 1.4 | -12.6 | |||||||||
cash-flows.row.other-non-cash-items | 43.65 | 11.5 | -18.3 | -0.1 | |||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -94.18 | 0 | 0 | 0 | |||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -1.51 | -1.5 | -3 | -1.3 | |||||||||
cash-flows.row.acquisitions-net | 26.56 | -9.7 | 31.5 | 89.8 | |||||||||
cash-flows.row.purchases-of-investments | -117.43 | -117.4 | -182.8 | -141.2 | |||||||||
cash-flows.row.sales-maturities-of-investments | 128.63 | 128.6 | 212.8 | 51.4 | |||||||||
cash-flows.row.other-investing-activites | 11.2 | 9.7 | 0.6 | -89.8 | |||||||||
cash-flows.row.net-cash-used-for-investing-activites | 9.69 | 9.7 | 59.2 | -91.1 | |||||||||
cash-flows.row.debt-repayment | 0 | 0 | -0.1 | 0 | |||||||||
cash-flows.row.common-stock-issued | 5.51 | 3 | 72.6 | 134.9 | |||||||||
cash-flows.row.common-stock-repurchased | 0.16 | 0 | 0 | 0 | |||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.other-financing-activites | -5.16 | 0.1 | 2.3 | 0.1 | |||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 5.74 | 3.1 | 74.8 | 135 | |||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 76.19 | 0 | 0 | 0 | |||||||||
cash-flows.row.net-change-in-cash | -81.37 | -81.4 | 36 | -33.9 | |||||||||
cash-flows.row.cash-at-end-of-period | 384.77 | 74 | 157.2 | 121.2 | |||||||||
cash-flows.row.cash-at-beginning-of-period | 466.14 | 155.4 | 121.2 | 155.1 | |||||||||
cash-flows.row.operating-cash-flow | -94.18 | -94.2 | -98 | -77.8 | |||||||||
cash-flows.row.capital-expenditure | -1.51 | -1.5 | -3 | -1.3 | |||||||||
cash-flows.row.free-cash-flow | -95.69 | -95.7 | -101 | -79 |
Řádek výkazu zisku a ztráty
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0 | 8.1 | 13.6 | |||||||||
income-statement-row.row.cost-of-revenue | 2.96 | 2.6 | 2.4 | 58.7 | |||||||||
income-statement-row.row.gross-profit | -2.96 | -2.6 | 5.7 | -45.1 | |||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||
income-statement-row.row.research-development | 76.56 | - | - | - | |||||||||
income-statement-row.row.selling-general-administrative | 27.75 | - | - | - | |||||||||
income-statement-row.row.selling-and-marketing-expenses | -0.59 | - | - | - | |||||||||
income-statement-row.row.other-expenses | 1.09 | 0 | -0.4 | 0 | |||||||||
income-statement-row.row.operating-expenses | 103.73 | 101.7 | 107.4 | 85.9 | |||||||||
income-statement-row.row.cost-and-expenses | 104.31 | 104.3 | 107.4 | 85.9 | |||||||||
income-statement-row.row.interest-income | 7.14 | 7.1 | 2.6 | 0.1 | |||||||||
income-statement-row.row.interest-expense | -1.96 | 0 | -20.5 | 0 | |||||||||
income-statement-row.row.selling-and-marketing-expenses | -0.59 | - | - | - | |||||||||
income-statement-row.row.total-other-income-expensenet | 6.35 | 8.3 | 20.5 | 0.1 | |||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||
income-statement-row.row.other-operating-expenses | 1.09 | 0 | -0.4 | 0 | |||||||||
income-statement-row.row.total-operating-expenses | 6.35 | 8.3 | 20.5 | 0.1 | |||||||||
income-statement-row.row.interest-expense | -1.96 | 0 | -20.5 | 0 | |||||||||
income-statement-row.row.depreciation-and-amortization | 2.96 | 2.6 | -1.5 | 3 | |||||||||
income-statement-row.row.ebitda-caps | -102.01 | - | - | - | |||||||||
income-statement-row.row.operating-income | -104.25 | -104.3 | -106.5 | -72.3 | |||||||||
income-statement-row.row.income-before-tax | -96.02 | -96 | -86 | -72.2 | |||||||||
income-statement-row.row.income-tax-expense | -4.56 | 0 | -20.5 | -0.1 | |||||||||
income-statement-row.row.net-income | -94.06 | -96 | -65.5 | -72.1 |
Často kladené otázky
Co je Solid Biosciences Inc. (SLDB) celková aktiva?
Solid Biosciences Inc. (SLDB) celková aktiva jsou 164939000.000.
Jaký je roční obrat podniku?
Roční příjmy jsou N/A.
Jaké je ziskové rozpětí podniku?
Zisková marže firmy je 0.000.
Jaký je volný peněžní tok podniku?
Volný peněžní tok je -4.694.
Jaká je čistá zisková marže podniku?
Čistá zisková marže je 0.000.
Jaké jsou celkové tržby podniku?
Celkové příjmy jsou 0.000.
Co je Solid Biosciences Inc. (SLDB) čistý zisk (čistý příjem)?
Čistý zisk (čistý příjem) je -96015000.000.
Jaký je celkový dluh podniku?
Celkový dluh je 26265000.000.
Jaké je číslo provozních nákladů?
Provozní výdaje jsou 101734000.000.
Jaké je číslo peněžních prostředků firmy?
Peněžní prostředky podniku jsou 74015000.000.